Shinya Sakata

Association of Probiotic <i>Clostridium butyricum</i> Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer

Yusuke Tomita, Tokunori Ikeda, Shinya Sakata et al. · Cancer Immunology Research · 2020 · 241 citations

Medicine, Immunology, Oncology +15

Achievement of High Fusion Performance in JT-60U Reversed Shear Discharges

S. Ishida, T. Fujita, H. Akasaka et al. · Physical Review Letters · 1997 · 101 citations

Natural Sciences, Nuclear Engineering, Physics +17

Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies

Ryo Sato, Kosuke Imamura, Shinya Sakata et al. · Journal of Clinical Medicine · 2019 · 89 citations · Full text

Life Sciences, Immunology, Oncology +17

Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation–positive non–small-cell lung cancer in a real-world setting (OSI-FACT)

Yoshihiko Sakata, Shinya Sakata, Yuko Oya et al. · European Journal of Cancer · 2021 · 89 citations

Medicine, Oncology, Pharmacology +12

<i>Clostridium butyricum</i> therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors

Yusuke Tomita, Yoshihiko Goto, Shinya Sakata et al. · OncoImmunology · 2022 · 89 citations · Full text

Life Sciences, Microbiology, Oncology +17